1. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. (1st April 2018) Authors: Rohr, Julia K.; Ive, Prudence; Horsburgh, Charles Robert; Berhanu, Rebecca; Hoffmann, Christopher J.; Wood, Robin; Boulle, Andrew; Giddy, Janet; Prozesky, Hans; Vinikoor, Michael; Mwanza, Mwanza wa; Wandeler, Gilles; Davies, Mary-Ann; Fox, Matthew P. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 77:Number 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Developing a predictive risk model for first‐line antiretroviral therapy failure in South Africa. Issue 1 (26th September 2016) Authors: Rohr, Julia K; Ive, Prudence; Horsburgh, C Robert; Berhanu, Rebecca; Shearer, Kate; Maskew, Mhairi; Long, Lawrence; Sanne, Ian; Bassett, Jean; Ebrahim, Osman; Fox, Matthew P Journal: Journal of the International AIDS Society Issue: Volume 19:Issue 1(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Does Disseminated Nontuberculous Mycobacterial Disease cause False-positive Determine TB-LAM Lateral Flow Assay Results?. (4th October 2017) Authors: Nel, Jeremy; Ive, Prudence; Berhanu, Ribka; Sanne, Ian; Spencer, David; Lippincott, Christopher Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Issue 9979 (2nd May 2015) Authors: Dawson, Rodney; Diacon, Andreas H; Everitt, Daniel; van Niekerk, Christo; Donald, Peter R; Burger, Divan A; Schall, Robert; Spigelman, Melvin; Conradie, Almari; Eisenach, Kathleen; Venter, Amour; Ive, Prudence; Page-Shipp, Liesl; Variava, Ebrahim; Reither, Klaus; Ntinginya, Nyanda E; Pym, Alexand... Journal: Lancet Issue: Volume 385:Issue 9979(2015) Page Start: 1738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Increases in regimen durability associated with the introduction of tenofovir at a large public‐sector clinic in Johannesburg, South Africa. Issue 1 (19th November 2013) Authors: Brennan, Alana T; Maskew, Mhairi; Ive, Prudence; Shearer, Kate; Long, Lawrence; Sanne, Ian; Fox, Matthew P Journal: Journal of the International AIDS Society Issue: Volume 16:Issue 1(2013) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa. Issue 9 (7th July 2016) Authors: Fox, Matthew P.; Berhanu, Rebecca; Steegen, Kim; Firnhaber, Cindy; Ive, Prudence; Spencer, David; Mashamaite, Sello; Sheik, Sadiyya; Jonker, Ingrid; Howell, Pauline; Long, Lawrence; Evans, Denise Journal: Tropical medicine & international health Issue: Volume 21:Issue 9(2016) Page Start: 1131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis. (1st August 2022) Authors: Inzaule, Seth C.; Kroeze, Stefanie; Kityo, Cissy M.; Siwale, Margaret; Akanmu, Sulaimon; Wellington, Maureen; de Jager, Marleen; Ive, Prudence; Mandaliya, Kishor; Stevens, Wendy; Steegen, Kim; Nankya, Immaculate; Boender, T. Sonia; Ondoa, Pascale; Sigaloff, Kim C.E.; de Wit, Tobias F. Rinke; Hame... Journal: AIDS Issue: Volume 36:Number 10(2022) Page Start: 1437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance. Issue 1 (December 2018) Authors: Inzaule, Seth; Kityo, Cissy; Siwale, Margaret; Akanmu, Alani; Wellington, Maureen; de Jager, Marleen; Ive, Prudence; Mandaliya, Kishor; Stevens, Wendy; Boender, T.; Ondoa, Pascale; Sigaloff, Kim; Naniche, Denise; Rinke de Wit, Tobias; Hamers, Raph Journal: Scientific reports Issue: Volume 8:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus–Tuberculosis Coinfection. (9th February 2021) Authors: Kendall, Michelle A; Lalloo, Umesh; Fletcher, Courtney V; Wu, Xingye; Podany, Anthony T; Cardoso, Sandra W; Ive, Prudence; Benson, Constance A Journal: Clinical infectious diseases Issue: Volume 73:Number 4(2021) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. (15th May 2018) Authors: Kroeze, Stefanie; Ondoa, Pascale; Kityo, Cissy M.; Siwale, Margaret; Akanmu, Sulaimon; Wellington, Maureen; de Jager, Marleen; Ive, Prudence; Mandaliya, Kishor; Stevens, Wendy; Boender, T. Sonia; de Pundert, Marieke E.; Sigaloff, Kim C.E.; Reiss, Peter; Wit, Ferdinand W.N.M.; Rinke de Wit, Tobias... Journal: AIDS Issue: Volume 32:Number 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗